Life Sciences Tools and Services
Company Overview of Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. provides development solutions and delivery technologies for drugs, biologics, and consumer health products. The company’s Development and Clinical Services segment offers manufacturing, packaging, storage, and inventory management services for drugs and biologics in clinical trials. This segment also provides analytical chemical and cell-based testing and scientific services; respiratory products formulation and manufacturing; regulatory consulting; and bioanalytical testing for biologic products. Its Oral Technologies segment offers oral delivery technologies, including formulation, development, and manufacturing services for the oral dose forms comprising p...
14 Schoolhouse Road
Somerset, NJ 08873
Key Executives for Catalent Pharma Solutions, Inc.
Chief Executive Officer, President and Director
Chief Financial Officer, Principal Accounting Officer and Executive Vice President
Senior Vice President of Global Operations
President of Advanced Delivery Technologies
President of Catalent Asia Pacific
Compensation as of Fiscal Year 2016.
Catalent Pharma Solutions, Inc. Key Developments
Arch Biopartners, Inc. Engages Catalent Inhalation to Begin the Manufacturing Process for its Drug Ab569
Aug 10 16
Arch Biopartners, Inc. announced it has engaged Catalent Inhalation, a division of Catalent Pharma Solutions to begin the manufacturing process for its drug AB569 in preparation for the first human trials involving patients with antibiotic resistant lung infections. Catalent Inhalation will commence with initial stability and formulation studies, which are both important production milestones in preparing a pharmaceutical product for human trials and eventual drug approval by the U.S. Food and Drug Administration and other health authorities. Once the stability and formulation work is completed with positive results, Arch will engage Catalent Inhalation to manufacture a supply of AB569 that meets good manufacturing practice (GMP) standards to enable human trials to treat cystic fibrosis and chronic obstructive pulmonary disease patients with chronic bacterial lung infections.
Catalent Pharma Solutions Opens New Clinical Supply Facility in Kakegawa, Japan
Jun 8 16
Catalent Pharma Solutions has announced the opening of its clinical supply facility, located within its 200,000sqft cGMP site in Kakegawa, Japan. The site will serve the needs of both domestic and global clinical trial sponsors with services including secondary packaging and labeling, clinical storage, distribution, project management and clinical supply management, and will complement the capabilities of other Catalent facilities in the Asia-Pacific region.
Catalent Pharma Solutions to Invest $4.6 Million to Expand Singapore Clinical Supply Facility
Feb 4 16
Catalent Pharma Solutions has announced that it will invest $4.6 million to further expand its Singapore clinical supply facility by building new GMP space for secondary packaging, doubling its ambient storage space, and quadrupling cold storage capacity. Customer demand at the site has increased by 30% over last year, and this expansion, coupled with recently announced opening of a facility in Japan, will allow Catalent to better support multinational customers' growing trial's needs, while providing more flexible solutions for local customers in the region.
Similar Private Companies By Industry
Recent Private Companies Transactions